CAMK2G and cardiac hypertrophy: In a hypertrophy-induced heart failure (HF) model, disrupting the βIV-spectrin-CaMKII interaction prevents CaMKII-induced degradation of spectrin, safeguarding the heart against hypertrophy-induced cardiac fibrotic remodeling and dysfunction.